Glenn Doody

Vice President, Product Management, Technology Innovation and Specialty Products
S&P Dow Jones Indices

Glenn Doody is Vice President, Product Management, Technology Innovation and Specialty Products at S&P Dow Jones Indices (S&P DJI). Glenn’s responsibilities include the oversight of development of innovative new technologies for S&P DJI products. In addition, Glenn is responsible for the S&P CoreLogic Case-Shiller Home Price Indices and S&P/Experian Consumer Credit Indices. In Glenn’s previous role as Chief Operating Officer of Trucost, he focused on improving growth opportunities, introducing processes aimed at increasing revenue generation and profitability, as well as technology development.

Glenn joined Standard & Poor’s (now S&P DJI) via the Toronto Stock Exchange (TSX) when operational control of the Canadian indices transferred from the TSX. From 1999 to 2003, Glenn led S&P DJI’s Canadian team to establish its business in Canada, as well as the launch of S&P DJI’s Australian team. In 2003, Glenn headed S&P DJI’s Asian business, including several product launches. Upon his return to New York, Glenn worked with Product Innovation, introducing products including the S&P Healthcare Indices, S&P CoreLogic Case-Shiller Home Price Indices, S&P Securities Lending Indices, S&P Carbon Efficient Indices, and the S&P Municipal Bond Index Series.

Prior to his work at S&P DJI and TSX, Glenn spent seven years in the investment banking industry as a quantitative analyst at Midland Walwyn Capital. He also spent time on the equity and derivatives trading desks and served as a member of the firm’s market strategy committee.

A Chartered Financial Analyst®, Glenn has a Bachelor of Arts in computer science and business administration from Memorial University of Newfoundland.

Author Archives: Glenn Doody

Walgreens case study – S&P Healthcare Claims Indices to better manage expectations

In late August, as reported by the Wall Street Journal, Walgreens announced the departure of their CFO at the end of the current year. This news came after a significant cut in forecasts by $1.1 billion from the original $8.5 billion forecast in fiscal 2016 pharmacy-unit earnings. According to the Wall Street Journal, “Walgreens hadn’t Read more […]

Using an independent measure of healthcare costs in labor negotiations

On May 27th, 2014 an article appeared in the Wall Street Journal titled “New Costs From Health Law Snarl Union Contract Talks”. This article provides an interesting insight into the challenges both employers and Unions face under the Affordable Healthcare Act as they try to determine the future cost of health plans that have been Read more […]

Healthcare growth drivers for the large employer market

An article published Friday in Healthcare Payer News, “How health inflation could slow, or rise, in 2014” indicates a projected 6.5% increase in the large employer medical inflation for 2014 by PWC Health. As can be seen by the S&P Healthcare Claims Indices, an index series comprised of claims data provided by leading insurers in Read more […]